Addendum: ACSL4: biomarker, mediator and target in quadruple negative breast cancer

PDF  |  How to cite

Oncotarget. 2023; 14:754-754. https://doi.org/10.18632/oncotarget.28482

Metrics: PDF 373 views  |   ?  

Marie E. Monaco1,2

1Department of Neuroscience and Physiology, NYU Grossman School of Medicine, New York, NY 10016, USA
2VA NY Harbor Healthcare System, New York, NY 10010, USA

Published: August 10, 2023

Copyright: © 2023 Monaco. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

This article has an addendum: No external funding was obtained with respect to this publication.

Original article: Oncotarget. 2023; 14:563-575. DOI: https://doi.org/10.18632/oncotarget.28453.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 28482